How Abbott's Big Win Crushed DexCom Shares
DiabetesHow Abbott's Big Win Crushed DexCom SharesHow Abbott's Big Win Crushed DexCom Shares
FDA’s surprise approval of Abbott’s FreeStyle Libre glucose monitoring system represents a huge win for the company, its partner Bigfoot, and diabetes patients everywhere. But the news dealt a heavy blow to competitor DexCom, which saw its shares crash more than 36%.
Sign up for the QMED & MD+DI Daily newsletter.